BioSpace News Archive

IDEXX Laboratories, Inc. has scheduled the release of its 2018 second quarter financial results for Wednesday, August 1 before the market opens.

Sage Therapeutics announced that, on July 2, 2018, the Compensation Committee of Sage’s Board of Directors granted non-qualified stock options to purchase an aggregate of 129,000 shares of its common stock to 31 new employees under Sage’s 2016 Inducement Equity Plan.

McKesson Corporation will release financial results for its first fiscal quarter ended June 30, 2018 on Thursday, July 26, 2018

MabVax Therapeutics Holdings, Inc. announced that as a result of the Company’s decision not to submit a plan to regain compliance with Nasdaq’s filing requirement, which a decision was announced by the Company in a press release on July 2, 2018, and, on that same date, the Listing Qualifications Staff (the “Staff”) of The Nasdaq Stock Market LLC (“Nasdaq”) notified the Company of its determination to delist the Company’s securities from Nasdaq.

LuMind RDS invites Dallas community to join the Miles for Breakthroughs 5K on July 14

Paragon 28® has launched innovative products and instrumentation to help streamline medical procedures, allow surgeons flexibility in technique and approach, and facilitate reproducible results benefitting both the surgeon and patient.

The final analysis at 18 months of the 856 patient Phase II clinical study in early Alzheimer’s disease demonstrated statistically significant slowing in clinical decline and reduction of amyloid beta accumulated in the brain

Lipogems announced U.S. Food and Drug Administration (FDA) clearance of the company’s Lipogems Microfragmented Adipose Tissue Transplant System.

Ritter Pharmaceuticals, Inc. announced that Andrew J. Ritter has been appointed to the position of CEO, effective June 27, 2018

Progressive Care, Inc. announced that it has engaged The Benchmark Company, LLC